## M2 and M4 â€“ High risk (Group C)

Cytarabine
-	Route: Subcutaneous
-	Dosage: 50 mg/m2/dose, every 12 hours
-	Dosage: 100 mg/m2/dose, in 250ml NS, continuous infusion over 20 hours  
-	Used on days 1 to 5 (total 10 doses)

Etoposide 
-	Route: IV infusion over 2 hours 
-	Dosage: 150 mg/m2/dose, diluted in 500ml to 1L NS (max concentration 0.4 mg/ml), infused over 2 hours 
-	Used on days 1 to 3 
